'Effectiveness' in the evaluation of new drugs: A misunderstood concept?

Canadian Journal of Clinical Pharmacology

Volumn 8, Issue 2, 2001, Pages 61-62

  Rawson, N S B ^a  

^a MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

NEW DRUG;

CANADA; CLINICAL PRACTICE; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DRUG EFFICACY; DRUG SCREENING; HIGH RISK POPULATION; HUMAN; OUTCOMES RESEARCH; PATIENT MONITORING; PRESCRIPTION; SHORT SURVEY;

EID: 0034889686     PISSN: 1198581X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (9)

1. Postmarketing surveillance in Canada
2. Could "conditional release" of new drugs provide the information required to study drug effectiveness? - A discussion paper
3. Efficacy, effectiveness, variations, and quality: Boundary-crossing research
4. Psychological risk factors may moderate pharmacological treatment effects among ischemic heart disease patients
5. Prescription-episodes to study drug utilization with the Saskatchewan drug plan datafile
6. Ascertaining how much compliance is enough with outpatient antibiotic regimens
7. Antibiotic prescribing for Canadian preschool children: Evidence of overprescribing for viral respiratory infections
8. Pilot study for appropriate anti-infective community therapy: Effect of a guideline-based strategy to optimize use of antibiotics